Drug research

BioThrax

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as AVA; Anthrax Vaccine Adsorbed; Anthrax Vaccine Adsorbed (AVA)

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Ciprofloxacin BioThrax Co-Administration StudyNCT01753115	Emergent BioSolutions	Phase 2	Completed	2013-08Actual
Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy AdultsNCT01491607	Emergent BioSolutions	Phase 3	Completed	2012-05Actual
VELOCITY: An Anthrax Vaccine Clinical StudyNCT03877926	Emergent BioSolutions	Phase 3	Completed	2020-08-06Actual
A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose LevelsNCT01770743	Emergent BioSolutions	Phase 2	Completed	2014-02Actual

Emergent BioSolutionsCompletedPrimary completion: 2013-08 · Actual

Trial details

Emergent BioSolutionsCompletedPrimary completion: 2012-05 · Actual

Trial details

Emergent BioSolutionsCompletedPrimary completion: 2020-08-06 · Actual

Trial details

Emergent BioSolutionsCompletedPrimary completion: 2014-02 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.